Inflammatory myofibroblastic tumor (pseudotumor) is a rare tumor belonging to the family of fibrous mesenchymal tumors. Though it usually involves lungs, but extrapulmonary site involvement, especially head and neck region is rare. In this paper, we are presenting a 26-year-old male patient, with inflammatory myofibroblastic tumor of maxilla, with a rare association with a prior history of idiopathic orbital inflammatory disease, treated medically. The patient was treated surgically with complete excision of the pathology from maxilla. This case report intents to review the controversies in management of this tumor and also to enlighten the possible association between the orbital and maxillary pseudotumor.
INTRODUCTION
Inflammatory myofibroblastic tumor (IMFT) or also known as inflammatory pseudotumor, plasma cell granuloma or pseudosarcomatous myofibroblastic lesion is a rare mesenchymal tumor, which usually involves the lungs. Numerous extrapulmonary sites have been described, like skin and soft tissue, spleen, heart, bladder, upper respiratory tract, mediastinum and kidney. 1 The upper respiratory tract involving the larynx, trachea, oropharynx and nasopharynx accounts for 11% of extrapulmonary cases. The remaining sites in the head and neck account for less than 5% of cases, including orbit, paranasal sinus, skull base and temporal bone. 2 The pathogenesis of this tumor is still an enigma and the rarity of this lesion worsens the matters further. Same concerns persist with the aspect of management of this tumor also. The probable inflammatory association of both the IMFT and orbital pseudotumor makes the coexistence of these lesions not just a coincidence, but a possible indicator to the common pathogenesis of these lesions. These diseases could well be a part of the spectrum of a same pathogenesis.
CASE REPORT
A 26-year-old male patient presented to us with complaints of persistent left-sided facial heaviness and occasional pain treatment was administered to the patient. The patient was advised a close follow-up after explaining a possibility of even a late recurrence. The repeat radiology after 6 months shows the patient to be disease free. The histopathology exhibited plasma cells, lymphocytes and spindle-shaped proliferating fibroblasts. The tumor was positive for vimentin and desmin, suggesting a myofibroblastic origin. There was no evidence of granulomas or mitotic figures (Fig. 2) .
DISCUSSION
IMFT was first described way back in 1939 by Brunn in lungs, but the term IMFT was initially proposed and the lesion originally described by Pettinato et al 3 4 These tumors are considered as tumors of intermediate biological potential with a tendency for local recurrence and <5% chance of distant metastasis. 5 The riddle of pathogenesis is far from solved with multiple hypotheses being proposed. It is believed to be inherited as a autosomal recessive or dominant with variable penetrance. 6, 7 Cytogenetic studies suggest a possible clonal rearrangement of 2p23, involving ALK receptor tyrosine kinase locus region, which have been detected in about 50% of cases. 8, 9 Another important association is, IMFTs, particularly those in the spleen and liver, harbor the Epstein-Barr virus in spindle cells. 10 In comparison the picture with orbital pseudotumor also is not too rosy. The exact pathogenesis is still not known, but a possible autoimmune origin with either viral, environmental or genetic factors acting as the trigger. 11 The possible immune basis and response to steroids, along with histopathological features of inflammatory infiltrate mainly of mature lymphocytes admixed with plasma cells, neutrophils, eosinophils and macrophages makes the diagnosis immune/inflammatory in origin. This suggests a possible common trigger for both pathologies. As the patient was diagnosed with IMFT, the primary point of concern was the possible mode of management and the prognosis expected in the patient. The literature clearly proves the IMFT to be a neoplastic lesion, but the lack of metastasis in cases involving head and neck made decisions of management more confusing. The options available were of surgery, steroid therapy, radiotherapy or chemotherapy. The neoplastic nature of pathology warranted a radical approach, but the slow growing nature (2 years), already PL negative vision in right eye, and good access made a conservative complete excision the best possible option. The steroid therapy and radiotherapy are usually limited to residual/recurrence or for intracranial lesions. Though trials of chemotherapy along with interferon were tried, but no consistent results are expected. 12 So our decision of doing sublabial excision rather than a maxillectomy, with steroid therapy or radiotherapy as stand by treatment options in case of recurrence seemed very apt. But, the slow growing nature and local invasion demand along term follow-up with a possibility of late recurrence. Our study though does not exactly characterize the pathogenesis; it just implicates the possible association of two tumors with very similar origin and possibly a varied spectrum of an common seed. Longterm studies with a larger number are required before the association can be confirmed. 
